Notis-McConarty Edward - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 6 filers reported holding NOVOZYMES A S DKK 2.0 in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Notis-McConarty Edward ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$249,591
-13.3%
6,2000.0%0.10%
-7.3%
Q2 2023$287,961
-8.8%
6,2000.0%0.11%
-12.7%
Q1 2023$315,676
+0.8%
6,2000.0%0.13%
-3.1%
Q4 2022$313,085
-1.5%
6,200
-1.6%
0.13%
-8.5%
Q3 2022$318,000
-26.9%
6,300
-13.1%
0.14%
-21.5%
Q2 2022$435,000
-42.6%
7,250
-34.2%
0.18%
-33.0%
Q1 2022$758,000
-42.2%
11,025
-31.1%
0.27%
-38.4%
Q4 2021$1,312,000
-9.0%
16,000
-24.1%
0.44%
-17.0%
Q3 2021$1,441,000
-21.7%
21,085
-13.8%
0.53%
-22.5%
Q2 2021$1,840,000
-2.0%
24,452
-16.9%
0.68%
-6.8%
Q1 2021$1,878,000
-0.2%
29,410
-10.5%
0.73%
-4.6%
Q4 2020$1,882,000
-9.4%
32,876
-0.7%
0.77%
-16.2%
Q3 2020$2,078,000
+11.2%
33,096
+2.2%
0.91%
+4.9%
Q2 2020$1,868,000
+27.5%
32,396
+0.8%
0.87%
+7.4%
Q1 2020$1,465,000
-3.6%
32,151
+3.2%
0.81%
+20.0%
Q4 2019$1,520,000
+16.5%
31,151
+0.1%
0.68%
+10.3%
Q3 2019$1,305,000
-9.8%
31,111
+0.0%
0.61%
-10.2%
Q2 2019$1,446,000
+1.4%
31,0960.0%0.68%
-0.9%
Q1 2019$1,426,000
+3.0%
31,0960.0%0.69%
-9.7%
Q4 2018$1,385,000
-18.8%
31,096
-0.2%
0.76%
-16.3%
Q3 2018$1,705,000
+9.9%
31,156
+1.6%
0.91%
-0.8%
Q2 2018$1,552,000
-0.1%
30,656
+1.7%
0.92%
-1.3%
Q1 2018$1,554,000
-9.6%
30,1560.0%0.93%
-5.7%
Q4 2017$1,719,000
+39.0%
30,156
+24.8%
0.99%
+27.4%
Q3 2017$1,237,000
+3.6%
24,156
-11.5%
0.78%
+0.3%
Q2 2017$1,194,000
-13.8%
27,296
-21.9%
0.77%
-15.0%
Q1 2017$1,385,000
+19.8%
34,971
+4.5%
0.91%
+14.2%
Q4 2016$1,156,000
-21.4%
33,481
+0.2%
0.80%
-20.8%
Q3 2016$1,470,000
-8.5%
33,4110.0%1.00%
-10.8%
Q2 2016$1,607,000
+7.5%
33,411
+0.4%
1.13%
+6.2%
Q1 2016$1,495,000
-0.5%
33,271
+6.7%
1.06%
-1.5%
Q4 2015$1,502,000
+21.5%
31,171
+9.9%
1.08%
+16.6%
Q3 2015$1,236,000
-7.4%
28,371
+1.1%
0.92%
+2.3%
Q2 2015$1,335,000
+6.4%
28,071
+2.4%
0.90%
+3.9%
Q1 2015$1,255,000
+8.2%
27,421
-0.2%
0.87%
+9.6%
Q4 2014$1,160,000
-2.8%
27,4710.0%0.79%
-5.6%
Q3 2014$1,193,000
-27.8%
27,471
-16.6%
0.84%
-23.1%
Q2 2014$1,652,000
+12.2%
32,921
-1.7%
1.09%
+6.4%
Q1 2014$1,473,000
+1.5%
33,496
-2.5%
1.03%
+1.0%
Q4 2013$1,451,00034,3461.02%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q3 2023
NameSharesValueWeighting ↓
Delaney Dennis R 32,907$1,897,0002.54%
Fayerweather Charles 22,858$1,318,0002.31%
SOMERVILLE KURT F 206,900$11,927,0002.20%
Gardiner Nancy B 22,350$1,288,0002.13%
Broderick Brian C 106,579$6,143,0002.04%
PUZO MICHAEL J 93,960$5,416,0002.03%
Kidder Stephen W 90,846$5,237,0002.00%
Page Arthur B 37,705$2,173,0001.92%
Dempze Nancy E 26,893$1,549,0001.73%
Hemenway Trust Co LLC 206,922$11,927,0001.66%
View complete list of NOVOZYMES A S DKK 2.0 shareholders